Breaking News
Date : 15 Apr 25
CTI’s Global Rise: Advancing Clinical Research from Cincinnati to the World
From its Cincinnati origins, CTI Clinical Trial & Consulting has grown into a global ...
Verve’s VERVE-102 Shows Strong Safety and Efficacy, Positions Lilly for Key 2025 Decision
Verve Therapeutics has reported encouraging early-phase results for VERVE-102, its ne...
Tempest Therapeutics Seeks Strategic Partners as Funding Dries Up for Liver Cancer Drug
Facing harsh financial headwinds, Tempest Therapeutics is actively pursuing strategic...
Ironwood Faces Setback as FDA Requires New Phase 3 Trial for GI Drug Apraglutide
Ironwood Pharmaceuticals must conduct another Phase 3 trial for apraglutide after the...
Synthetic Suppressor T Cells Offer Precision Immunosuppression Without Systemic Risks
Researchers have engineered synthetic T cells to locally suppress immune responses, p...
Scientists Call for a Ban on Mirror Bacteria Research Over Safety Concerns
-
admin
2025/04/15
10
A group of leading synthetic biologists urges a halt to mirror bacteria research due ...
Anthrobots: Human-Cell Robots That Build Bridges and Heal
In a groundbreaking study, researchers have developed “anthrobots” — living robots ma...
Overcoming the Next Frontier: Industry Experts Tackle Challenges in Cell and Gene Therapy at GenScript Biotech Forum 2025
At the 2025 GenScript Biotech Global Forum, leaders in the biotech sector applauded t...
-
- 1
- 2
-
Please Accept Cookies for Better Performance